CLU rs11136000: Understanding the Clusterin Variant and Brain Health
The rs11136000 variant is a single nucleotide polymorphism located within the CLU gene, which encodes the protein clusterin. Research has consistently linked this variant to differences in Alzheimer's disease risk and variations in brain structure and function among older adults.
What each genotype means
Increased Alzheimer's risk profile
This genotype is associated with a higher statistical risk for late-onset Alzheimer's disease compared to those carrying the T allele. Research suggests this variant may influence clusterin protein levels and brain white matter integrity, though these associations are complex and do not guarantee any specific health outcome.
This is the most common genotype in populations of European ancestry.
Reduced Alzheimer's risk profile
Carrying one copy of the T allele is associated with a slight protective effect against late-onset Alzheimer's disease compared to the C/C genotype. This variant is thought to play a role in how the brain manages amyloid-beta proteins, though the overall impact on individual health remains a subject of ongoing research.
This heterozygous genotype is found in a significant portion of the population across many ancestries.
Reduced Alzheimer's risk profile
This genotype is associated with a slight protective effect against late-onset Alzheimer's disease compared to the C/C genotype. While this variant is linked to better performance on certain cognitive assessments in some studies, it is only one of many factors that contribute to long-term brain health.
This is the least common genotype for this variant in many populations of European ancestry.
What is rs11136000?
The rs11136000 variant is a specific genetic change, or single nucleotide polymorphism (SNP), located on chromosome 8. It sits within an intron of the CLU gene. In genetics, an intron is a non-coding region of a gene that is removed during the process of creating a protein. While it does not directly change the sequence of the protein itself, variants in these regions can influence how much of a protein is produced or when it is expressed in different tissues. Scientists identify this specific location as rs11136000, a unique identifier used in global databases to track this exact position in the human genome. Because it is a common variant, it has been extensively studied in large-scale genome-wide association studies (GWAS) to understand its role in complex health conditions.
The Role of the CLU Gene
The CLU gene provides instructions for making a protein called clusterin, also known as Apolipoprotein J. Clusterin is a multifunctional protein found in many body fluids and tissues, including the brain. In the context of neurobiology, clusterin is thought to play a protective role by binding to amyloid-beta peptides, which are proteins that can misfold and accumulate in the brains of individuals with Alzheimer's disease. By binding to these peptides, clusterin may help prevent them from clumping together into toxic plaques and assist in their clearance from the brain's extracellular space. Because of this function, researchers have long hypothesized that variations in the CLU gene could influence how effectively the brain manages these proteins, potentially impacting the risk of neurodegenerative decline as people age.
Research and Evidence Strength
The association between rs11136000 and Alzheimer's disease is well-documented in scientific literature, though the evidence is considered limited in terms of clinical predictability. Multiple large-scale studies have identified the C allele as a risk factor for late-onset Alzheimer's disease, often noting that it confers a modest increase in odds compared to other major genetic risk factors like APOE-e4. Research has also explored how this variant relates to brain imaging, with some studies suggesting that carriers of the risk allele may show subtle differences in hippocampal volume or neural activation patterns during memory tasks. However, it is important to note that these findings are statistical associations observed in large populations. They do not mean that carrying a specific genotype guarantees a particular health outcome, as Alzheimer's is a complex condition influenced by many genetic, environmental, and lifestyle factors.
Population Frequency
The rs11136000 variant is relatively common in human populations. In European ancestry groups, the minor allele frequency is approximately 0.36 to 0.38. This means that a significant portion of the population carries at least one copy of the variant. Because it is so common, it is considered a standard variation rather than a rare mutation. Frequency can vary across different global populations, and researchers often account for these differences when conducting genetic studies to ensure that findings are robust and applicable across diverse groups. Understanding these frequencies helps scientists determine the prevalence of the variant and its potential impact on public health on a broader scale.
Interpreting Your Genetic Information
If you have access to your genetic data, you may see your genotype for rs11136000 listed as CC, CT, or TT. It is crucial to understand that this information is for educational purposes only and should not be used to diagnose or predict your personal health future. Genetic associations are based on averages across thousands of people and cannot account for your unique medical history, lifestyle, or other genetic factors. If you are concerned about cognitive health or neurodegenerative disease, the most appropriate step is to consult with a qualified healthcare professional or a genetic counselor. They can help you interpret your health risks in the context of your overall well-being and provide guidance on evidence-based preventative strategies. Never make medical decisions based solely on a single genetic variant.
How common is this variant?
The rs11136000 variant is common, with a minor allele frequency of approximately 0.36 in European populations.
Frequently asked questions
Does having the C allele mean I will get Alzheimer's?
No. The C allele is a statistical risk factor, not a diagnostic one. Many people with the C allele never develop Alzheimer's, and many people without it do.
Can I change my risk associated with this SNP?
While you cannot change your genetics, you can focus on modifiable lifestyle factors known to support brain health, such as regular exercise, a balanced diet, and cognitive engagement. Always discuss your health concerns with a doctor.
Is this the same as the APOE gene?
No, CLU and APOE are different genes. While both are associated with Alzheimer's risk, they function differently in the body and are located on different chromosomes.
Where can I find more information on this variant?
You can search for 'rs11136000' on reputable databases like the GWAS Catalog or NCBI's dbSNP. These resources provide access to the original research papers and clinical data.
Sources & further reading
Educational information only, last refreshed 9/28/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs11136000?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29